Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded accessFrancesca Fumagalli, Alessandro Aiuti, Valeria Calbi et al.|The Lancet|2022Cited by 286
Hematologic Cancer after Gene Therapy for Cerebral AdrenoleukodystrophyChristine Duncan, David A. Williams, Jörn‐Sven Kühl et al.|New England Journal of Medicine|2024Cited by 119
Lentiviral Gene Therapy for Cerebral AdrenoleukodystrophyFlorian Eichler, David A. Williams, Christine Duncan et al.|New England Journal of Medicine|2024Cited by 71